Brief: Rua Bioscience Posts Preliminary Unaudited Annual Results
28/08/2026 01:29
BRIEF-Rua Bioscience Posts Preliminary Unaudited Annual Results Aug 28 (Reuters) - Rua Bioscience Ltd RUA.NZ:
PRELIMINARY UNAUDITED ANNUAL RESULTS
SALES ARE ANTICIPATED TO MAINTAIN AN UPWARD TRAJECTORY THROUGH FY27
FOCUS FOR FY27 IS ON CONTINUING SALES GROWTH ACROSS MARKETS OF NEW ZEALAND, AUSTRALIA, GERMANY, UNITED KINGDOM
FOCUS FOR FY27 IS BUILDING OUT NEW REVENUE STREAMS FROM EMERGING MARKETS INCLUDING CZECHIA, CANADA
Further company coverage: RUA.NZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rua Bioscience
See all newsBrief: Rua Bioscience Partners With Curaleaf Laboratories For UK Distribution
Brief: Rua Bioscience Partners To Supply Medicinal MDMA In New Zealand
Brief: Pharmala Biotech Holdings Rua Bioscience And Pharmala Biotech Partner To Supply Medicinal Mdma In New Zealand
Brief: Rua Bioscience Posts Preliminary Unaudited Annual Results
New Zealand's Rua Bioscience FY customer revenue jumps on Australia, NZ growth